PASSARIELLO, MARGHERITA
 Distribuzione geografica
Continente #
AS - Asia 1.261
EU - Europa 1.086
NA - Nord America 842
SA - Sud America 181
AF - Africa 38
OC - Oceania 1
Totale 3.409
Nazione #
US - Stati Uniti d'America 796
SG - Singapore 614
RU - Federazione Russa 536
CN - Cina 321
IT - Italia 302
BR - Brasile 143
HK - Hong Kong 121
VN - Vietnam 83
DE - Germania 72
NL - Olanda 53
IN - India 43
GB - Regno Unito 25
FR - Francia 23
CA - Canada 20
MX - Messico 20
KR - Corea 19
CI - Costa d'Avorio 15
FI - Finlandia 15
ZA - Sudafrica 15
JP - Giappone 13
AT - Austria 12
PL - Polonia 11
BD - Bangladesh 10
EC - Ecuador 10
AR - Argentina 9
PY - Paraguay 8
SE - Svezia 8
ES - Italia 7
ID - Indonesia 7
IQ - Iraq 7
BE - Belgio 4
CO - Colombia 4
IE - Irlanda 4
LT - Lituania 4
TR - Turchia 4
EG - Egitto 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MY - Malesia 2
PE - Perù 2
PK - Pakistan 2
SA - Arabia Saudita 2
UA - Ucraina 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
VE - Venezuela 1
Totale 3.409
Città #
Singapore 292
Naples 150
Moscow 141
Hong Kong 121
Beijing 97
Hefei 94
Ashburn 91
Chandler 78
Santa Clara 68
Amsterdam 49
Los Angeles 46
Ho Chi Minh City 34
San Jose 32
Napoli 24
Munich 22
Boston 20
São Paulo 20
Dallas 19
Pune 18
Seoul 18
Lawrence 17
New York 16
Ercolano 14
Seattle 14
Hanoi 13
Redondo Beach 13
Frankfurt am Main 11
Tokyo 11
Buffalo 10
Des Moines 10
Kochi 10
Millbury 10
The Dalles 10
Capaccio 9
Falkenstein 9
Brooklyn 8
Düsseldorf 8
Helsinki 8
Nuremberg 8
Rome 8
Warsaw 8
Chicago 7
London 7
Mexico City 7
Toronto 7
Atlanta 6
Columbus 6
Denver 6
Orem 6
Wilmington 6
Acerra 5
Johannesburg 5
Quito 5
Shanghai 5
Vienna 5
Brussels 4
Cape Town 4
Chennai 4
Guangzhou 4
Haiphong 4
Houston 4
Lappeenranta 4
Marano di Napoli 4
Nanjing 4
Poplar 4
Portsmouth 4
Thái Bình 4
Bexley 3
Biên Hòa 3
Calgary 3
Campinas 3
Casavatore 3
Caserta 3
Ciudad del Este 3
Lauterbourg 3
Milan 3
Montreal 3
New Delhi 3
Phoenix 3
Pozzuoli 3
Queens 3
Rio de Janeiro 3
Salvador 3
Shijiazhuang 3
Stockholm 3
Trentola-Ducenta 3
Uberlândia 3
Wuhan 3
Araruama 2
Asunción 2
Baghdad 2
Bauru 2
Berlin 2
Bernalda 2
Bình Dương 2
Bắc Giang 2
Campi Bisenzio 2
Charlotte 2
Da Nang 2
Dhaka 2
Totale 1.877
Nome #
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab 151
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model 141
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2 128
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 126
Long-chain polyphosphates impair SARS-CoV-2 infection and replication 125
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries 121
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies. 119
A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells 117
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells 115
Fusion proteins 111
Novel combinations of human immunomodulatory mAbs lacking cardiotoxic effects for therapy of TNBC 111
Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes 110
Interactions of spike‐rbd of sars‐cov‐2 and platelet factor 4: New insights in the etiopathogenesis of thrombosis 108
Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics 106
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy 105
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC 103
Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology 103
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling 103
Immunomodulatory mabs as tools to investigate on cis-interaction of pd-1/pd-l1 on tumor cells and to set up methods for early screening of safe and potent combinatorial treatments 102
Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo 101
HUMAN ANTI-FV ANTIBODY, THERAPEUTIC AND DIAGNOSTIC APPLICATIONS THEREOF 101
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand 101
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma 100
Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells. 100
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays 97
Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell Killing 96
T-cell Activating Tribodies as a Novel Approach for Efficient Killing of ErbB2-positive Cancer Cells. 95
A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies 86
Superior Suppression of ErbB2-positive Tumor Cells by a Novel Human Triparatopic Tribody 85
Evidences of CTLA-4 and PD-1 blocking agents-induced cardiotoxicity in cellular and preclinical models 83
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways 82
Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab 66
A Novel Human Anti-FV mAb as a Potential Tool for Diagnostic and Coagulation Inhibitory Approaches 62
Generation of novel human anti-OX-40 mAbs endowed with different biological properties as tools for cancer therapy 30
Totale 3.490
Categoria #
all - tutte 11.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 4 0 19 11 0
2021/2022145 0 4 1 1 1 4 16 9 10 21 41 37
2022/2023241 19 12 9 13 29 25 0 24 37 46 23 4
2023/2024234 10 28 52 21 9 39 10 25 0 2 23 15
2024/20251.273 48 33 23 32 32 111 112 76 66 153 508 79
2025/20261.488 267 198 253 212 397 118 43 0 0 0 0 0
Totale 3.490